0A9B logo

SYNLAB Share Price

Symbol: LSE:0A9BMarket Cap: €2.8bCategory: Healthcare

0A9B Share Price Performance

0A9B Community Fair Values

    Recent 0A9B News & Updates

    No updates

    SYNLAB AG Key Details

    €2.6b

    Revenue

    €604.9m

    Cost of Revenue

    €2.0b

    Gross Profit

    €1.9b

    Other Expenses

    €89.3m

    Earnings

    Last Reported Earnings
    Mar 31, 2024
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    0.41
    Gross Margin
    76.87%
    Net Profit Margin
    3.42%
    Debt/Equity Ratio
    39.0%

    SYNLAB AG Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About 0A9B

    Founded
    1998
    Employees
    27000
    CEO
    Mathieu Floreani
    WebsiteView website
    www.synlab.ag

    SYNLAB AG provides medical diagnostic services and specialty testing services in Europe. It also offers diagnostics for veterinary medicine. The company serves hospitals, practicing doctors, clinics, patients, governments, and corporations. SYNLAB AG was founded in 1998 and is headquartered in Munich, Germany.

    German Market Performance

    • 7 Days: 0.7%
    • 3 Months: 5.3%
    • 1 Year: 19.1%
    • Year to Date: 14.2%
    The Consumer Discretionary sector gained 5.8% while the market remained flat over the last week. More promisingly, the market is up 19% over the past year. Earnings are forecast to grow by 16% annually. Market details ›
    Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
    Continue reading